Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 1 regulatory subunit 36 (PPP1R36) is a regulatory protein that associates with and modulates the activity of protein phosphatase 1 (PP1), a critical serine/threonine phosphatase involved in diverse cellular processes. PPP1R36 is not itself an enzyme or receptor but acts to bind and inhibit PP1 phosphatase activity as part of larger protein complexes. It has been shown to promote autophagy, particularly in the context of gonadal development and spermatogenesis, likely through interaction with autophagy factors such as Atg16L1. PPP1R36 expression is enriched during testis development and may be involved in the early stages of sperm cell formation; however, its specific molecular targets and broader physiological and disease roles remain incompletely defined. There are currently no known therapeutic agents that target PPP1R36 directly, and it is not widely recognized as a clinical drug target or biomarker.
Not applicable (PPP1R36 is a regulatory protein, not directly targeted by drugs; any modulatory action would theoretically involve protein-protein interactions with PP1 or autophagy-related factors)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 36 (PPP1R36).